A hybrid CRO scaling the peaks of biopharma research
K2bio is a hybrid Contract Research Organization (CRO) enabling early-stage life science companies to develop the next generation of innovative therapies.
Our mission is to provide comprehensive help and support along the way.
We offer a state-of-the-art facility with experienced research managers and staff and an on-site vivarium. Our mix of private and shared research laboratory space offers affordable access for early-stage biopharmaceutical companies. In addition, our team provides guidance and phase-appropriate regulatory oversight throughout the product research and development lifecycle.